Announcements Trials

Browse Landscape

Phase

Status

Completed 93 Terminated 36 Unknown 12 Withdrawn 4 Active not recruiting 3 Recruiting 2 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1

Interventions

Carboplatin 126 Cisplatin 125 Drug Therapy 103 Bevacizumab 98 Oxaliplatin 97 Capecitabine 97 Radiotherapy 94 Gemcitabine 87 Paclitaxel 85 tislelizumab 84 Cyclophosphamide 82 pembrolizumab 77 Specimen Handling 77 toripalimab 69 Injections 63 Fluorouracil 62 Magnetic Resonance Spectroscopy 61 sintilimab 57 anlotinib 53 130-nm albumin-bound paclitaxel 51 Surgical Procedures, Operative 50 Docetaxel 49 fludarabine 46 Pemetrexed 45 venetoclax 42 Standard of Care 42 Leucovorin 42 Irinotecan 41 lenvatinib 40 Biopsy 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × Alemtuzumab × Clear all

NCT06084780 2026-06-05

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡